ATE513214T1 - Gelzusammensetzungen - Google Patents

Gelzusammensetzungen

Info

Publication number
ATE513214T1
ATE513214T1 AT02745605T AT02745605T ATE513214T1 AT E513214 T1 ATE513214 T1 AT E513214T1 AT 02745605 T AT02745605 T AT 02745605T AT 02745605 T AT02745605 T AT 02745605T AT E513214 T1 ATE513214 T1 AT E513214T1
Authority
AT
Austria
Prior art keywords
gel
analyte
moieties
sol
entities
Prior art date
Application number
AT02745605T
Other languages
English (en)
Inventor
Margaret Joan Taylor
Original Assignee
Univ Montfort
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montfort filed Critical Univ Montfort
Application granted granted Critical
Publication of ATE513214T1 publication Critical patent/ATE513214T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/559—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody through a gel, e.g. Ouchterlony technique
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548—Carbohydrates, e.g. dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Colloid Chemistry (AREA)
AT02745605T 2001-07-10 2002-07-10 Gelzusammensetzungen ATE513214T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0116860.8A GB0116860D0 (en) 2001-07-10 2001-07-10 Gel compositions
PCT/GB2002/003183 WO2003006993A2 (en) 2001-07-10 2002-07-10 Gel compositions

Publications (1)

Publication Number Publication Date
ATE513214T1 true ATE513214T1 (de) 2011-07-15

Family

ID=9918254

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02745605T ATE513214T1 (de) 2001-07-10 2002-07-10 Gelzusammensetzungen

Country Status (9)

Country Link
US (1) US8247391B2 (de)
EP (1) EP1407267B1 (de)
JP (2) JP2004534103A (de)
AT (1) ATE513214T1 (de)
DK (1) DK1407267T3 (de)
ES (1) ES2368036T3 (de)
GB (1) GB0116860D0 (de)
PT (1) PT1407267E (de)
WO (1) WO2003006993A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0116860D0 (en) 2001-07-10 2001-09-05 Univ Montfort Gel compositions
DE10254636A1 (de) * 2002-11-22 2004-06-09 Capsulution Nanoscience Ag Verfahren zum Modifizieren von Mikropartikeln sowie Vorrichtung zum Modifizieren von Mikropartikeln
CA2583308C (en) * 2004-10-08 2020-01-07 Georgia Tech Research Corporation Microencapsulation of cells in hydrogels using electrostatic potentials
KR20110106440A (ko) * 2009-01-14 2011-09-28 코넬 유니버시티 생체의료 용도를 위한 생분해성 히드로겔의 제법
CN101745114B (zh) * 2009-12-25 2013-01-23 浙江工业大学 一种对葡萄糖敏感可自控释胰岛素的生物材料的制备方法
US20140350370A1 (en) * 2013-04-08 2014-11-27 The Texas A&M University System Glucose sensing assay
GB201310185D0 (en) 2013-06-07 2013-07-24 Univ Montfort Container
GB201314640D0 (en) * 2013-08-15 2013-10-02 Univ Montfort Matrix gel
TN2017000439A1 (en) 2015-04-21 2019-04-12 Univ North Carolina State Glucose-responsive insulin delivery system using hyoxia-sensitive nanocomposites
US11141486B2 (en) * 2015-10-23 2021-10-12 National University Corporation Tokyo Medical And Dental University Drug delivery device
CN110167537A (zh) 2016-11-07 2019-08-23 北卡罗来纳州立大学 用于增强葡萄糖反应性胰岛素的递送的装有双敏感囊泡的贴剂
NO343313B1 (en) * 2017-03-15 2019-01-28 Lifecare As Fluid composition, method for preparing the composition and use
AU2019402149A1 (en) * 2018-12-18 2021-06-24 Johnson & Johnson Consumer Inc. Personalized topical application patch
GB2599818B (en) * 2019-06-04 2024-01-31 Thirty Respiratory Ltd Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
EP3980373A1 (de) * 2019-06-04 2022-04-13 Thirty Holdings Limited Verfahren und zusammensetzungen zur erzeugung von stickstoffmonoxid und verwendungen davon
TWI899548B (zh) * 2023-03-13 2025-10-01 羅怡情 染髮用凝膠的用途及製法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705503A (en) * 1986-02-03 1987-11-10 Regents Of The University Of Minnesota Metabolite sensor including a chemical concentration sensitive flow controller for a drug delivery system
GB9200638D0 (en) * 1992-01-10 1992-03-11 Leicester Polytechnic Drug system
DE4203466A1 (de) * 1992-02-04 1993-08-05 Rudolf Prof Dr Ehwald Affinitaets-sensor
GB9313484D0 (en) * 1993-06-30 1993-08-11 Univ Montfort Drug system ii
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
JP3536186B2 (ja) * 1995-02-27 2004-06-07 独立行政法人 科学技術振興機構 生体内分解性高分子ヒドロゲル
US5889028A (en) * 1996-02-09 1999-03-30 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
WO1998022097A2 (en) 1996-11-20 1998-05-28 Bio Advances, Llc Controlled release matrix composition using polar polymer or monomer and poly(acrylic acid) blend
GB9805896D0 (en) 1998-03-20 1998-05-13 Eglise David Remote analysis system
JP4199421B2 (ja) 1998-08-10 2008-12-17 アムジエン・インコーポレーテツド デキストラン−レプチン結合体、医薬組成物および関連方法
EP1212601A4 (de) * 1999-08-27 2006-03-29 Biotech Inc M Glukosebiosensor
GB0116860D0 (en) 2001-07-10 2001-09-05 Univ Montfort Gel compositions

Also Published As

Publication number Publication date
PT1407267E (pt) 2011-09-19
JP2011144197A (ja) 2011-07-28
US20040265386A1 (en) 2004-12-30
EP1407267A2 (de) 2004-04-14
JP2004534103A (ja) 2004-11-11
GB0116860D0 (en) 2001-09-05
WO2003006993A2 (en) 2003-01-23
DK1407267T3 (da) 2011-09-19
US8247391B2 (en) 2012-08-21
JP5405511B2 (ja) 2014-02-05
WO2003006993A3 (en) 2003-09-25
EP1407267B1 (de) 2011-06-15
ES2368036T3 (es) 2011-11-11

Similar Documents

Publication Publication Date Title
ATE513214T1 (de) Gelzusammensetzungen
FR14C0064I2 (fr) Anticorps anti-il-6, compositions, methodes et utilisations associees
TR200102029T2 (tr) 1-Heterosiklil ikameli diarilaminler.
ATE465748T1 (de) Vernetzte, nicht von pilzen kommende lipase enthaltende zusammensetzung und methoden zu deren verwendung
DK1273304T4 (da) Anvendelse af interleukin-15
MA27035A1 (fr) Ligands de recepteurs de 5-ht et leurs utilisations
DE60014348D1 (de) Messung und verwendung von molekularen wechselwirkungen
DE50105338D1 (de) Neuartige polymerbindersysteme mit ionischen flüssigkeiten
TR200102401T2 (tr) C-21 Değiştirilmiş epotilonlar.
BR0200472B1 (pt) composiÇço de fluido de hidrocarboneto lÍquido em forma de gel, e, agente de formaÇço de gel de lÍquido de hidrocarboneto.
ATE412432T1 (de) Internalisierende erbb2 antikörper
DE69840599D1 (de) Antimikrobielle chinolone, ihre zusammensetzungen und ihre verwendungen
WO2005058283A3 (en) Stabilised compositions of factor vii polypeptides
EP1572881A4 (de) Polypeptide tacis und br3 sowie verwendungen davon
ATE343378T1 (de) Biologisch abbaubares alginatgel mit verzögerter freisetzung
TR200000740T2 (tr) Dişleri beyazlatmak için metod ve kompozisyonlar.
ATE209622T1 (de) Triaromatische verbindungen, diese enthaltende zusammensetzungen sowie ihre anwendungen
NO995591L (no) Geler med forsinket, langvarig frigjörelse
WO2003016428A3 (en) Triboluminescent materials and devices containing them
ATE426638T1 (de) Formulierung enthaltend eine anionische verbindung, ein polyionisches polymer und ein copolymer
TR200100455T2 (tr) Nimesulid içeren topikal farmasötik bileşimler
BR0109846A (pt) Uso de uma composição que compreende um anticorpo ou um fragmento de ligação de antìgeno deste, e conjunto
WO2002017919A3 (en) Use of threo-methylphenidate compounds to enhance memory
TR200002987T2 (tr) Optik özelliklere sahip olan poli (Alkilen Arilatlar).
TR199701092T1 (xx) Sukralfat içeren farmakotik kompozisyonlar.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1407267

Country of ref document: EP